{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T14:57:22Z","timestamp":1648565842002},"reference-count":8,"publisher":"Informa Healthcare","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1517\/14656566.6.10.1761","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T18:03:09Z","timestamp":1123524189000},"page":"1761-1764","source":"Crossref","is-referenced-by-count":1,"title":["CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction"],"prefix":"10.1517","volume":"6","author":[{"given":"Sheila A","family":"Doggrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,8,8]]},"reference":[{"key":"CIT0001","first-page":"838","volume":"45","author":"WEINTRAUB WS","year":"2005","journal-title":"[.AMY A et al.: Long-term cost effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J. Am. Coll. Cardiol"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050522"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE STEERING COMMITTEE","year":"1996","journal-title":"Lancet"},{"key":"CIT0004","first-page":"494","volume":"345","author":"YUSUSF S","year":"2001","journal-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl. J. Med."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140675.85342.1B"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000029926.71825.E2"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","volume":"108","author":"PETERS RJ","year":"2003","journal-title":"Circulation"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00149831-200412000-00003","volume":"11","author":"LAMY A","year":"2004","journal-title":"Eur. Cardiovasc. Prey. Rehabil"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.6.10.1761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T22:00:56Z","timestamp":1497650456000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.6.10.1761"}},"subtitle":["WEINTRAUB WS, MAHONEY EM, LAMY A<i>et al.<\/i>: Long-term cost effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.<i>J. Am. Coll. Cardiol.<\/i>(2005)<b>45<\/b>: 838-845 [1] and SABATINE MS, CANNON CP, GIBSON CM<i>et al.<\/i>: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.<i>N. Engl. J. Med.<\/i>(2005)<b>352<\/b>:1179-1189 [2]."],"short-title":[],"issued":{"date-parts":[[2005,8,8]]},"references-count":8,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2005,8,8]]},"published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1517\/14656566.6.10.1761"],"URL":"https:\/\/doi.org\/10.1517\/14656566.6.10.1761","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,8]]}}}